Titre:
  • A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer.
Auteur:Siena, Salvatore; Piccart-Gebhart, Martine; Holmes, Frankie A; Glaspy, John; Hackett, James; Renwick, Jennifer
Informations sur la publication:Oncology Reports, 10, 3, page (715-724)
Statut de publication:Publié, 2003
Sujet CREF:Cancérologie
MeSH keywords:Aged
Antineoplastic Agents -- therapeutic use
Body Weight
Breast Neoplasms -- drug therapy -- pathology
Double-Blind Method
Female
Granulocyte Colony-Stimulating Factor -- administration & dosage -- analogs & derivatives
Humans
Injections, Subcutaneous
Middle Aged
Neoplasm Staging
Neutropenia -- chemically induced -- prevention & control
Recombinant Proteins
Note générale:Clinical Trial
Journal Article
Multicenter Study
Randomized Controlled Trial
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1021-335X
info:scp/0043248410
info:pmid/12684649